GlyT-1 Inhibitor Treatment for Refractory Schizophrenia
NCT01251055
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Treatment Refractory
Interventions
DRUG:
GlyT-1 inhibitor-1
DRUG:
Placebo
Sponsor
China Medical University Hospital